Postpartum atypical hemolytic uremic syndrome with complement factor H mutation complicated by reversible cerebrovascular constriction syndrome successfully treated with eculizumab.
Municipal Yokkaichi Hospital, Yokkaichi, Japan.
Makoto
M
Yamaguchi
Municipal Yokkaichi Hospital, Yokkaichi, Japan.
Mayuko
M
Hori
Municipal Yokkaichi Hospital, Yokkaichi, Japan.
Nagaya
N
Hiroshi
Department of Nephrology, Nagoya University Graduate School of Medicine, Nagoya, Japan. Electronic address: marus@med.nagoya-u.ac.jp.
Shoichi
S
Maruyama
D000328:Adult; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D065766:Atypical Hemolytic Uremic Syndrome / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D017242:Complement Factor H / Q000235:genetics / Q000378:metabolism; D005260:Female; D006801:Humans; D009154:Mutation; D049590:Postpartum Period
D061067:Antibodies, Monoclonal, Humanized; C493495:CFH protein, human; D017242:Complement Factor H; C481642:eculizumab
Atypical hemolytic uremic syndrome; Complement factor H; Eculizumab; Pregnancy